iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU...

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• The MAPT gene's H1 haplotype is a known risk factor for neurodegenerative diseases like Parkinson's.
• The precise molecular mechanisms underlying this increased risk are not fully understood.
• Existing models often lack the specific MAPT haplotype crucial for studying disease pathogenesis.

Purpose of the Study:

• To develop and characterize novel human cell lines modeling MAPT haplotypes for neurodegenerative disease research.
• To establish a resource for identifying MAPT-dependent cellular phenotypes.
• To investigate the differential effects of H1 and H2 MAPT haplotypes on tau and alpha-synuclein.

Main Methods:

• Generation of eight small molecule neural precursor cell lines (smNPCs) homozygous for MAPT H1/H1 (n=4) and H2/H2 (n=4) haplotypes.
• Utilized a rapid differentiation protocol involving NEUROGENIN-2 overexpression for high-throughput analysis.
• Performed basic characterization and comparative analysis of TAU and alpha-synuclein profiles over 30 days of differentiation.

Main Results:

• Identified higher levels of conformationally altered TAU in H2/H2 MAPT haplotype cell lines.
• Observed increased expression of alpha-synuclein in H1/H1 MAPT haplotype cell lines.
• Established distinct molecular profiles associated with each MAPT haplotype during neuronal differentiation.

Conclusions:

• The developed smNPCs provide a valuable tool for studying MAPT-dependent phenotypes in neurodegenerative diseases.
• This resource can help elucidate the molecular mechanisms underlying tauopathies and related disorders.
• The findings contribute to improved in vitro modeling for sporadic tauopathies using induced pluripotent stem cells (iPSCs).